Cannabis Cardiol Therapeutics Reports Exercise and Closing of Over-Allotment OptionBy Alexander LeeOctober 12, 20240 On October 11, 2024, a clinical-stage life sciences company based in Oakville, Ontario announced the successful completion of a public…
Cannabis Cardiol Therapeutics Inc. Completes US$13.5 Million Public Offering of Common SharesBy Alexander LeeOctober 10, 20240 On October 10, 2024, Cardiol Therapeutics Inc., a clinical-stage life sciences company focused on researching and developing anti-inflammatory and anti-fibrotic…
